Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting

Journal of Asthma

Volumn 53, Issue 3, 2016, Pages 321-329

  Westerik, Janine A M ^a   Carter, Victoria ^b   Chrystyn, Henry ^a,c   Burden, Anne ^a   Thompson, Samantha L ^a   Ryan, Dermot ^d,e   Gruffydd Jones, Kevin ^f   Haughney, John ^g   Roche, Nicolas ^h   Lavorini, Federico ⁱ   Papi, Alberto ^j   Infantino, Antonio ^k   Roman Rodriguez, Miguel ^l   Bosnic Anticevich, Sinthia ^m   Lisspers, Karin ⁿ   Ställberg, Björn ⁿ   Henrichsen, Svein Høegh ^o,p   Van Der Molen, Thys ^p   Hutton, Catherine ^a   Price, David B ^a,g  

^a Research in Real Life Ltd   (United Kingdom)

^b Optimum Patient Care Ltd   (United Kingdom)

^c Inhalation Consultancy Ltd   (United Kingdom)

^d Woodbrook Medical Centre   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f University of Aberdeen ^*  (United Kingdom)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ CAREGGI UNIVERSITY HOSPITAL   (Italy)

^j UNIVERSITY OF FERRARA   (Italy)

^k Special Interest Respiratory Area   (Italy)

^l HEALTH RESEARCH INSTITUTE OF THE BALEARIC ISLANDS IDISBA   (Spain)

^m UNIVERSITY OF SYDNEY   (Australia)

ⁿ UPPSALA UNIVERSITY   (Sweden)

^o UNIVERSITY OF OSLO   (Norway)

^p UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

Asthma therapy; cross sectional; Diskus inhaler; inhalation devices; multinational

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTHMA; BREATH HOLDING; CROSS-SECTIONAL STUDY; DRY POWDER INHALER; EXHALATION; FEMALE; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; INHALATION; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RISK FACTOR; THERAPEUTIC ERROR; AGE; BODY MASS; CLINICAL TRIAL; EDUCATIONAL STATUS; EQUIPMENT DESIGN; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PRIMARY HEALTH CARE; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADMINISTRATION, INHALATION; ADULT; AGE FACTORS; AGED; ASTHMA; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DRY POWDER INHALERS; EDUCATIONAL STATUS; EQUIPMENT DESIGN; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS; SEX FACTORS;

EID: 84958038358     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2015.1099160     Document Type: Article

References (48)

1. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST.Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-47.
2. Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010;19:150-157.
3. Price D, Fletcher M, van der Molen T. Asthma control and management in 8 000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med 2014;24:14009.
4. Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, Bousquet J. Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 2013;107:37-46.
5. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011;37: 1308-1331.
6. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127:335-371.
7. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001;5:1-149.
8. Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs. Respir Med 2010;104: 1237-1245.
9. Papi A, Haughney J, Virchow JC, Roche N, Palkonen S, Price D. Inhaler devices for asthma: a call for action in a neglected field. Eur Respir J 2011;37:982-985.
10. Wright J, Brocklebank D, Ram F. Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD). Qual Saf Health Care 2002;11:376-382.
11. Manzella BA, Brooks CM, Richards Jr. JM, Windsor RA, Soong S, Bailey WC. Assessing the use of metered dose inhalers by adults with asthma. J Asthma 1989;26:223-230.
12. van Beerendonk I, Mesters I, Mudde AN, Tan TD. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998;35:273-279.
13. Melani AS, Zanchetta D, Barbato N, Sestini P, Cinti C, Canessa PA, Aiolfi S, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol 2004;93:439-446.
14. Schulte M, Osseiran K, Betz R, Wencker M, Brand P, Meyer T, Haidl P. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv 2008;21:321-328.
15. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008;102:593-604.
16. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105: 930-938.
17. Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med 2011;105:1815-1822.
18. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19: 246-251.
19. Al-Jahdali H, Ahmed A, Al-Harbi A, Khan M, Baharoon S, Bin Salih S, Halwani R, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol 2013;9:8.
20. Levy ML, Hardwell A, McKnight E, Holmes J. Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J 2013;22:406-411.
21. Melani AS. Inhalatory therapy training: a priority challenge for the physician. Acta Biomed 2007;78:233-245.
22. Chrystyn H. The Diskus: a review of its position among dry powder inhaler devices. Int J Clin Pract 2007;61:1022-1036.
23. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003;16:249-254.
24. Broeders ME, Molema J, Hop WC, Vermue NA, Folgering HT. The course of inhalation profiles during an exacerbation of obstructive lung disease. Respir Med 2004;98:1173-1179.
25. Haughney J, Sims E, Holohan J, Ryan D, Price D. Improving clinician-patient communication in asthma: the HARP project. Allergy 2010;65:413-414.
26. Carter V. iHARP Database. Respiratory Effectiveness Group, 2015 Winter Summit; Rotterdam 2015. Available from: http://www.ef fectivenessevaluation.org/reg-2015-winter-summit/ [last accessed 19 June 2015].
27. Inhaler technique assessment initiative Helping Asthma in Real-life Patients (iHARP): Web resource. Available from: https://iharp.org/ [last accessed 19 June 2015].
28. Respiratory Effectiveness Group. Available from: http://www.ef fectivenessevaluation.org/ [last accessed 19 June 2015].
29. Study registration, European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), 2014. Available from: http://www.encepp.eu/encepp/viewResource.htm? id=8020 [last accessed 19 June 2015].
30. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002;17:17-32.
31. Global Initiative for Asthma. GINA report, Global Strategy for Asthma Management and Prevention. Available from: http:// www.ginasthma.org/ [last accessed 19 June 2015].
32. Vollmer WM, Markson LE, O'Connor E, Sanocki LL, Fitterman L, Berger M, Buist AS. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999;160: 1647-1652.
33. Lee SM, Chang YS, Kim CW, Kim TB, Kim SH, Kwon YE, Lee JM, et al. Skills in handling turbuhaler, diskus, and pressurized metered-dose inhaler in korean asthmatic patients. Allergy Asthma Immunol Res 2011;3:46-52.
34. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000;94:496-500.
35. O'Byrne PM, Pedersen S, Schatz M, Thoren A, Ekholm E, Carlsson LG, Busse WW. The poorly explored impact of uncontrolled asthma. Chest 2013;143:511-523.
36. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495-503.
37. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218-224.
38. Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, Canessa PA, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med 2006;19:127-136.
39. Kamin WE, Genz T, Roeder S, Scheuch G, Cloes R, Juenemann R, Trammer T. The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient. J Aerosol Med 2003;16:21-29.
40. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care 2005; 50:617-623.
41. Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhalerbased reminder labels, to improve asthma inhaler technique. Patient Educ Couns 2008;72:26-33.
42. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol 2007;119:1537-1538.
43. Takemura M, Kobayashi M, Kimura K, Mitsui K, Masui H, Koyama M, Itotani R, et al. Repeated instruction on inhalation technique improves adherence to the therapeutic regimen in asthma. J Asthma 2010;47:202-208.
44. Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma 2007;44:593-598.
45. Ho SF, O'Mahony MS, Steward JA, Breay P, Burr ML. Inhaler technique in older people in the community. Age Ageing 2004;33: 185-188.
46. Azouz W, Chetcuti P, Hosker HS, Saralaya D, Stephenson J, Chrystyn H. The inhalation characteristics of patients when they use different dry powder inhalers. J Aerosol Med Pulm Drug Deliv 2015;28:35-42.
47. Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenberg J, Barnes PJ. Importance of inhaler devices in the management of airway disease. Respir Med 2008;102:10-19.
48. Broeders ME, Sanchis J, Levy ML, Crompton GK, Dekhuijzen PN. The ADMIT series-issues in inhalation therapy. 2. Improving technique and clinical effectiveness. Prim Care Respir J 2009;18: 76-82.